Curiox Biosystems Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	30,064	17,909	5,597	11,003	7,043
Short-Term Investments	-	-	3,125	8,816	809.54
Cash & Short-Term Investments	30,064	17,909	8,722	19,819	7,853
Cash Growth	47.98%	105.34%	-55.99%	152.38%	-
Accounts Receivable	741.48	1,723	1,832	1,240	1,146
Other Receivables	140.84	98.19	68.97	86.29	86.63
Receivables	882.32	1,821	1,901	1,326	1,232
Inventory	1,681	1,621	2,911	1,759	595.7
Prepaid Expenses	-	173.81	79.92	23.37	12.77
Other Current Assets	2,673	75.54	336.57	132.05	197.54
Total Current Assets	35,300	21,601	13,949	23,060	9,891
Property, Plant & Equipment	2,144	2,391	998.06	543.1	427.33
Long-Term Investments	-	-	-	0	-0
Goodwill	24,836	23,547	22,733	21,143	19,819
Other Intangible Assets	9,744	10,056	10,761	10,969	11,196
Other Long-Term Assets	211.86	203.37	185.77	78.5	32.68
Total Assets	72,237	57,798	48,627	55,793	41,367
Accounts Payable	191.18	330	929.48	937.19	127.39
Accrued Expenses	411.6	375.03	537.34	441.11	201
Short-Term Debt	-	-	-	30,148	11,857
Current Portion of Leases	385.9	358.97	219.12	56.96	25.65
Current Unearned Revenue	471.77	669.72	539.41	286.02	107.22
Other Current Liabilities	16,093	982.85	609.44	411.63	353.16
Total Current Liabilities	24,557	2,717	2,835	32,281	12,672
Long-Term Debt	-	-	-	-	126.73
Long-Term Leases	367.59	606.19	168.09	241.58	157.86
Long-Term Deferred Tax Liabilities	1,655	1,592	1,764	1,564	1,734
Other Long-Term Liabilities	-0	-	0	0	-0
Total Liabilities	26,580	4,915	4,767	34,087	14,690
Common Stock	8,048	4,011	3,284	543	543
Additional Paid-In Capital	85,233	88,965	71,651	27,944	27,944
Retained Earnings	-55,217	-45,466	-35,426	-23,931	-9,407
Comprehensive Income & Other	7,588	5,369	4,344	1,027	-1,805
Total Common Equity	45,653	52,879	43,853	5,582	17,274
Minority Interest	4.57	4.93	7.82	10.82	10.13
Shareholders' Equity	45,657	52,883	43,861	21,707	26,677
Total Liabilities & Equity	72,237	57,798	48,627	55,793	41,367
Total Debt	7,757	965.16	387.21	30,446	12,168
Net Cash (Debt)	22,307	16,944	8,334	-10,627	-4,315
Net Cash Growth	13.00%	103.30%	-	-	-
Net Cash Per Share	1390.10	1186.03	1174.42	-1630.92	-662.17
Filing Date Shares Outstanding	16.1	16.04	13.14	6.52	6.52
Total Common Shares Outstanding	16.1	16.04	13.14	6.52	6.52
Working Capital	10,743	18,884	11,115	-9,221	-2,781
Book Value Per Share	2836.14	3295.64	3337.89	856.64	2651.04
Tangible Book Value	11,072	19,276	10,359	-26,530	-13,741
Tangible Book Value Per Share	687.83	1201.37	788.46	-4071.57	-2108.88
Machinery	-	2,440	1,219	740.14	704.78

Source: S&P Capital IQ. Standard template. Financial Sources.